Safety and efficacy of non-vitamin K oral anticoagulant treatment compared with warfarin in patients with non-valvular atrial fibrillation who develop acute ischemic stroke or transient ischemic attack: a multicenter prospective cohort study (daVinci study) Naoki SajiKazumi KimuradaVinci Study Group OriginalPaper 20 May 2016 Pages: 453 - 462
Prescriber knowledge and attitudes regarding non-administration of prescribed pharmacologic venous thromboembolism prophylaxis Kara L. PiechowskiStacy ElderKenneth M. Shermock OriginalPaper 21 May 2016 Pages: 463 - 470
Heparin-induced thrombocytopenia: reducing misdiagnosis via collaboration between an inpatient anticoagulation pharmacy service and hospital reference laboratory Allison E. BurnettHarmony BowlesCharles Mahan OriginalPaper 26 May 2016 Pages: 471 - 478
The use of anti-factor Xa monitoring in a selection of patients receiving enoxaparin at a large academic medical center Gretchen L. SachaKatie M. GreenleeJeffrey M. Ketz OriginalPaper 02 June 2016 Pages: 479 - 485
Patient satisfaction with extended-interval warfarin monitoring Nicholas W. CarrisAndrew Y. HwangKatherine Vogel Anderson OriginalPaper 01 June 2016 Pages: 486 - 493
A post hoc analysis of dalteparin versus oral anticoagulant (VKA) therapy for the prevention of recurrent venous thromboembolism (rVTE) in patients with cancer and renal impairment Seth WoodruffGuillaume FeugèreFrank Jen OriginalPaper Open access 25 June 2016 Pages: 494 - 504
Venous thromboembolism does not share familial susceptibility with retinal vascular occlusion or glaucoma: a nationwide family study Bengt ZöllerXinjun LiKristina Sundquist OriginalPaper 09 June 2016 Pages: 505 - 512
Outcomes associated with observation stays versus inpatient admissions for pulmonary embolism Erin R. WeedaW. Frank PeacockCraig I. Coleman OriginalPaper 20 June 2016 Pages: 513 - 519
Expression of tissue factor and forkhead box transcription factor O-1 in a rat model for chronic thromboembolic pulmonary hypertension Chaosheng DengDawen WuShuang Wu OriginalPaper 19 August 2016 Pages: 520 - 528
Use of signals and systems engineering to improve the safety of warfarin initiation G. HyunJ. LiB. F. Gage OriginalPaper 21 July 2016 Pages: 529 - 533
Erratum to: Use of signals and systems engineering to improve the safety of warfarin initiation G. HyunJ. LiB. F. Gage Erratum 24 August 2016 Pages: 534 - 534
Effects of non-vitamin K antagonist oral anticoagulants on fibrin clot and whole blood clot formation, integrity and thrombolysis in patients with atrial fibrillation Yee Cheng LauQinmei XiongAndrew D. Blann OriginalPaper Open access 23 August 2016 Pages: 535 - 544
Persistent neutrophilia is a marker for an increased risk of venous thrombosis Margarita KushnirHillel W. CohenHenny H. Billett OriginalPaper 06 July 2016 Pages: 545 - 551
The IgG and IgM isotypes of anti-annexin A5 antibodies: relevance for primary antiphospholipid syndrome Mirjana Bećarević ReviewPaper 15 June 2016 Pages: 552 - 557
High platelet reactivity after P2Y12-inhibition in patients with atrial fibrillation and coronary stenting Jonathan RilingerMelanie MeyerChristoph B. Olivier OriginalPaper 07 July 2016 Pages: 558 - 565
Renal function in atrial fibrillation patients switched from warfarin to a direct oral anticoagulant Anum S. MinhasQingmei JiangGeoffrey D. Barnes OriginalPaper 23 May 2016 Pages: 566 - 572
Direct oral anticoagulant use and the incidence of bleeding in the very elderly with atrial fibrillation Fatima KhanHans HuangYvonne H. Datta OriginalPaper 12 August 2016 Pages: 573 - 578
Effects of intermittent pneumatic compression of the thigh on blood flow velocity in the femoral and popliteal veins: developing a new physical prophylaxis for deep vein thrombosis in patients with plaster-cast immobilization of the leg Keisuke NakanishiNaonobu TakahiraJun Kitagawa OriginalPaper 02 August 2016 Pages: 579 - 584
Missing data on 3-month modified Rankin Scale may influence results of functional outcome after intravenous thrombolysis in observational studies Stefano ForlivesiManuel CappellariPaolo Bovi Letter to the Editor 23 June 2016 Pages: 585 - 585
Correlation between ADAMTS13 activity and neurological impairment in acute thrombotic microangiopathy patients Giulia Berti de MarinisStefano NovelloAnna Maria Lombardi OriginalPaper 05 July 2016 Pages: 586 - 592
Reasons for exclusion from intravenous thrombolysis in stroke patients admitted to the Stroke Unit Manuel CappellariMariachiara BoscoPaolo Bovi OriginalPaper 06 August 2016 Pages: 593 - 599
Late outcomes after acute pulmonary embolism: rationale and design of FOCUS, a prospective observational multicenter cohort study Stavros V. KonstantinidesStefano BarcoPhilipp S. Wild OriginalPaper Open access 30 August 2016 Pages: 600 - 609
An rs13293512 polymorphism in the promoter of let-7 is associated with a reduced risk of ischemic stroke Li ZhangJunsu YangXiang Ma OriginalPaper 16 August 2016 Pages: 610 - 615
Treatment of heparin-induced thrombocytopenia before and after the implementation of a hemostatic and antithrombotic stewardship program Brianne M. RitchieKatelyn W. SylvesterJean M. Connors OriginalPaper 08 August 2016 Pages: 616 - 622